Heterologous regulation of muscarinic and beta-adrenergic receptors in rat Cardiomyocytes in culture

Life Sciences

Volumn 63, Issue 13, 1998, Pages 1169-1182

  Mysliveček, Jaromír ^a,b   Lisá, Věra ^a   Trojan, Stanislav ^b   Tuček, Stanislav ^a  

^a INSTITUTE OF PHYSIOLOGY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

adrenoceptors; Adenylate cyclase; In vivo cardiomyocytes; Muscarinic receptors; Protein kinase A; Protein kinase C; Receptor regulation

Indexed keywords

4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; ADENYLATE CYCLASE; BETA ADRENERGIC RECEPTOR; CARBACHOL; CELL SURFACE RECEPTOR; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; DIMETHYLAMINOPROPYL BIS INDOLYLMALEIMIDE; FORSKOLIN; ISOPRENALINE; METHYLSCOPOLAMINE; MUSCARINIC RECEPTOR; N (2 GUANIDINOETHYL) 5 ISOQUINOLINESULFONAMIDE; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL MEMBRANE; DRUG RECEPTOR BINDING; ENZYME ACTIVATION; HEART MUSCLE CELL; LIGAND BINDING; NONHUMAN; RAT; RECEPTOR BINDING; RECEPTOR DENSITY;

ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BINDING SITES; BINDING, COMPETITIVE; BUCLADESINE; CARBACHOL; CELLS, CULTURED; CYCLIC AMP; ENZYME INHIBITORS; FEMALE; FORSKOLIN; INDOLES; ISOPROTERENOL; ISOQUINOLINES; KINETICS; MALE; MALEIMIDES; MUSCARINIC AGONISTS; MYOCARDIUM; N-METHYLSCOPOLAMINE; PROPANOLAMINES; PROTEIN KINASE C; RADIOLIGAND ASSAY; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA; RECEPTORS, MUSCARINIC; SULFONAMIDES; THIONUCLEOTIDES; TRITIUM;

EID: 0032555319     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(98)00378-6     Document Type: Article

References (41)

1. 1. J.L. BENOVIC, M. BOUVIER, M.G. CARON and R.J. LEFKOWITZ, Annu. Rev. Cell. Biol. 4, 405-428 (1988).
2. 2. R.C. ARMSTRONG and M.R. MONTMINY, Annu. Rev. Neurosci. 16, 17-29 (1993).
3. 3. J.D. PORT and C.G. MALBON, Trends Cardiovasc. Med. 3, 85-92 (1993).
4. 4. T.T. CHUANG, L. IACOVELLI, M. SALLESE and A. DE BLASI, Trends Pharmacol. Sci. 17, 416-421 (1996).
5. 5. O.-E. BRODDE, Pharmac. Ther. 60, 405-430 (1993).
6. 6. O.-E. BRODDE, M.C. MICHEL and H.-R. ZERKOWSKI, Cardiovasc. Res. 30, 570-584 (1995).
7. 7. T. ESCHENHAGEN, U. MENDE, M. DEIDERICH, B. HERTLE, C. MEMMESHEIMER, A. POHL, W. SCHMITZ, H. SCHOLZ, M. STEINFATH, M. BÖHM, M.C. MICHEL, O.-E. BRODDE and A. RAAP, Circulation 93, 763-771 (1996).
8. 8. P. SCHNABEL and M. BÖHM, Cell Signal. 8, 413-423 (1996).
9. 9. M. CASTELLANO and M. BÖHM, Hypertension 29, 715-722 (1997).
10. 10. J. MYSLIVEČEK, S. TROJAN and S. TUČEK, Life Sci. 58, 2423-2430 (1996).
11. 11. J. JAKUBÍK and S. TUČEK, Brit. J. Pharmacol. 113, 1529-1537 (1994).
12. 12. G.L. PETERSON, Analyt. Biochem. 83, 346-356 (1997).
13. 13. D. TOULLEC, P. PIANETTI, H. COSTE, P. BELLEVERGUE, T. GRAND-PERRET, M. AJAKANE, V. BAUDET, P. BOISSIN, E. BOURSIER, F. LORIOLLE, L. DUHAMEL, D. CHARON and J. KIRILOVSKY, J. Biol. Chem. 266, 15771-15781 (1991).
14. 14. L.H.P. BOTELHO, J.D. ROTHERMEL, R.V. COOMBS and B. JASTORFF, Methods Enzymol. 159, 159-172 (1988).
15. 15. H. HIDAKA, M. INAGAKI, S. KAWAMOTO and Y. SASAKI, Biochemistry 23, 5036-5041 (1984).
16. 16. J.P. LINDEMANN and A.M. WATANABE, Physiology and Pathophysiology of the Heart, N. Sperelakis (ed) 423-452, Kluwer Academic Publishers, Boston (1989).
17. 17. J.B. GALPER and T.W. SMITH, J. Biol. Chem. 255, 9571-9579 (1980).
18. 18. J.B. GALPER, L.C. DZIEKAN, D.S. O'HARA and T.W. SMITH, J. Biol. Chem. 257, 10344-10356 (1982).
19. 19. E.M. SUBERS and N.M. NATHANSON, J. Mol. Cell. Cardiol. 20, 131-140 (1988).
20. 20. B.M. GRANDORDY, J.C.W. MAK and P.J. BARNES, Life Sci. 54, 185-191 (1994).
21. 21. S.L. BROWN and J. H. BROWN, Mol. Pharmacol. 24, 351-356 (1983).
22. 22. M. BOUVIER, L.M.F. LEEB-LUNDBERG, J.L. BENOVIC, M.G. CARON and R.J. LEFKOWITZ, J. Biol. Chem. 262, 3106-3113 (1987).
23. 23. W.C. LILES, D.D. HUNTER, K.E. MEIER and N.M. NATHANSON, J. Biol. Chem. 261, 5307-5313 (1986).
24. 24. J. ROUSELL, E.-B. HADDAD, J.C.W. MAK and P.J. BARNES, J. Biol. Chem. 270, 7213-7218 (1995).
25. 25. W.S. LAI, T.N. ROGERS and E.E. EL-FAKAHANY, Biochem. J. 267, 23-29, (1990).
26. 26. J.M. HARE, J.F. KEANEY, J.-L. BALLIGAND, J. LOSCALZO and T.W. SMITH, J. Clin. Invest. 95, 360-366 (1995).
27. 27. C.J. LIMAS, and C. LIMAS, Biochem. Biophys. Res. Commun. 128, 699-704 (1985).
28. 28. A. PARASCHOS and J.S. KARLINER, Naunyn-Schmiedeberg's Arch. Pharmacol. 350, 267-276 (1994).
29. 29. C. REITHMANN and K. WERDAN, Naunyn-Schmiedeberg's Arch. Pharmacol. 351, 27-34, (1995).
30. 30 N.H. LEE and C.M. FRASER, J. Biol. Chem. 268, 7949-7957 (1993).
31. 31. J. ROUSELL, E.-B. HADDAD, J.C.W. MAK, B.L.J. WEBB, M.A. GIEMBYCZ and P.J. BARNES, Mol. Pharmacol. 49, 629-635 (1996).
32. 32. C. REITHMANN, B. PANZNER and K. WERDAN, Naunyn-Schmiedeberg's Arch. Pharmacol. 345, 530-540 (1992).
33. 33. D.A. JACKSON and N.M. NATHANSON, J. Biol. Chem. 270, 22374-22377 (1995).
34. 34. J.M. MATTHEWS, P.H.J. FALCKH, P. MOLENAAR and R.J. SUMMERS, Naunyn-Schmiedeberg's Arch. Pharmacol. 213, 213-225 (1996).
35. 35. S. COLLINS, M. BOUVIER, M.A. BOLANOWSKI, M.G. CARON and R.J. LEFKOWITZ, Proc. Natl. Acad. Sci. USA 86, 4853-4857 (1989).
36. 36. S. COLLINS, J. ALTSCHMIED, O. HERBSMAN, M.G. CARON, P.L. MELLON and R.J. LEFKOWITZ, J. Biol. Chem. 265, 19330-19335 (1990).
37. 37. S.-Z. ZHU, S.-Z. WANG, E.A.M. ABDALLAH and E.E. EL-FAKAHANY, Life Sci. 48, 2579-2584 (1991).
38. 38. H. CHOU, N. OGAWA, M. ASANUMA, H. HIRATA, Y. KONDO and A. MORI, Mol. Brain Res. 19, 211-214 (1993).
39. 39. M.C. STEEL and N.J. BUCKLEY, Mol. Pharmacol. 43, 694-701 (1993).
40. 40. R. BRUSA, S.R. GAMALERO, E. GENAZZANI and C. EVA, Eur. J. Pharmacol. 289, 9-16 (1995).
41. 41. M. STAEHELIN, P. SIMONS, K. JAEGGI and N. WIGGER, J. Biol. Chem. 258, 3496-3502 (1983).